Studies of Esophageal Metaplasia Using a Novel Antibody: Reversibility of Columnar Metaplasia by Proton Pump Inhibitor.
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2013
At a glance
- Drugs Pantoprazole; Ranitidine
- Indications Barrett's oesophagus
- Focus Therapeutic Use
- 15 Dec 2009 Planned end date changed from 1 Oct 2007 to 1 Oct 2006 as reported by ClinicalTrials.gov.
- 15 Dec 2009 Actual initiation date changed from Nov 2002 to Dec 2002 as reported by ClinicalTrials.gov.
- 03 Aug 2009 New trial record